COMMUNIQUÉS West-GlobeNewswire

EURneffy (adrenaline nasal spray) Approved in the EU as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

26/08/2024 - 15:29

EURneffy offers adults and children (≥30 kg) in Europe living with severe allergic reactions the first new delivery method for adrenaline in more than 30 years in the EU European Commission decision follows FDA approval [...]

Healthcare Integrated Technologies, Inc. Welcomes Micheal J. Burt to its Board of Directors

26/08/2024 - 15:25

Knoxville, Tennessee, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies, Inc. (“HiTC”), a leading innovator in healthcare solutions, is proud to announce the appointment of Micheal J. Burt to its [...]

Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

26/08/2024 - 15:15

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announces its participation in the Morgan Stanley 22nd Annual Global [...]

Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

26/08/2024 - 15:14

REYKJAVIK, Iceland, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announces its [...]

Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024

26/08/2024 - 15:10

SOUTH SAN FRANCISCO, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the [...]

Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference

26/08/2024 - 15:00

YARDLEY, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its [...]

Positron Corporation Announces Sale of NeuSight PET-CT Scanner

26/08/2024 - 15:00

Niagara Falls, NY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission [...]

Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11

26/08/2024 - 15:00

TORONTO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain [...]

Dewpoint Therapeutics Awarded Target ALS Grant for the Second Time for Development of c-mods for Amyotrophic Lateral Sclerosis (ALS)

26/08/2024 - 15:00

Grant to support the in vivo development of first-in-class condensate-modifying drugs (c-mods) targeting the TDP-43 condensatopathy in ALS BOSTON, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics Inc. , the [...]

EverythingALS Launches New Mobile App: A Comprehensive Research and Life Navigation Tool for the ALS Community

26/08/2024 - 15:00

SEATTLE, Aug. 26, 2024 (GLOBE NEWSWIRE) -- EverythingALS is proud to announce the launch of its new mobile app, now available on both the iOS and Android marketplaces. This app represents a significant upgrade from the [...]

Le KFSHRC établit de nouvelles normes mondiales en matière de formation aux soins de santé numériques

25/08/2024 - 14:54

RIYAD, Arabie saoudite, 25 août 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) tire parti de technologies innovantes pour améliorer l’éducation et la formation médicales en [...]

Innovative Training and Simulation Propel KFSHRC to Global Leadership in Medical Education

25/08/2024 - 10:46

RIYADH, Saudi Arabia, Aug. 25, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is revolutionizing clinical training through its iLearn Portal and comprehensive simulation-based [...]

KFSHRC Sets New Global Standards in Digital Healthcare Education

24/08/2024 - 12:21

RIYADH, Saudi Arabia, Aug. 24, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is leveraging innovative technologies to enhance medical education and training, rolling out ground- [...]

Le KFSHRC propose des programmes de recherche innovants aux futurs leaders du secteur de la santé

24/08/2024 - 11:43

RIYAD, Arabie saoudite, 24 août 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) renforce sa position de leader dans l’éducation et la recherche médicale grâce à son Département [...]

Capital and Business Alliance Formed Between MEDIROM MOTHER Labs and NFES Technologies

24/08/2024 - 03:12

NFES Group Selected as Lead Investor in Series A Round Valued at 9 Billion Yen TOKYO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Koji Eguchi; listed on [...]

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

24/08/2024 - 00:45

SAN DIEGO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced [...]

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

23/08/2024 - 23:20

FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing Qualifications [...]

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

23/08/2024 - 23:00

BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of [...]

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

23/08/2024 - 23:00

FLORHAM PARK, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced [...]